BP856

氯丙嗪 盐酸盐

British Pharmacopoeia (BP) Reference Standard

• 别名: 2-氯-10-(3-二甲氨基丙基)吩噻嗪 盐酸盐, CPZ, 氯普马嗪
• 经验公式（希尔记法）: C₁₇H₁₉ClN₂S · HCl
• CAS号: 69-09-0
• 分子量: 355.33
• Beilstein: 3779989
• MDL编号: MFCD00012654
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: chlorpromazine
• 表单: solid
• 保质期: limited shelf life, expiry date on the label
• 制造商/商品名称: BP
• 应用: pharmaceutical; pharmaceutical small molecule
• 包装形式: neat
• 储存温度: 2-8°C
• SMILES字符串: Cl[H].CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13
• InChI: 1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H
• InChI key: FBSMERQALIEGJT-UHFFFAOYSA-N
• 基因信息: human ... DRD2(1813) , DRD3(1814) , DRD4(1815) , HTR2A(3356)

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

在血红蛋白和过氧化物酶的微量测定中替代联苯胺、邻联茴香胺和邻联甲苯胺。

Chlorpromazine hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Chlorpromazine

Chlorpromazine Suppositories

生化/生理作用

吩噻嗪类抗精神病药;D₂ 多巴胺受体拮抗剂，H₁ 组胺受体拮抗剂;抑制钙调蛋白依赖性环核苷酸磷酸二酯酶和一氧化氮合成酶的活化。

氯丙嗪表现出对白血病细胞的细胞毒性和抗增殖活性，但是不会影响正常淋巴细胞的活力。

包装

Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS06
• 警示用语：: Danger
• 危险声明: H301,H330
• 预防措施声明: P260 - P264 - P270 - P271 - P284 - P304 + P340 + P310
• 危险分类: Acute Tox. 1 Inhalation - Acute Tox. 3 Oral
• 储存分类代码: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable